NR3C2 and type 2 diabetes mellitus: In outpatients with T2D, HFrEF is infrequent and can be ruled out with a low MR-proANP level, [2] which is important as therapies have been shown to reduce both morbidity and mortality in patients with HFrEF irrespective of concomitant T2D [4].